Arsanis, Inc. Appoints Michael P. Gray As Chief Financial Officer And Chief Business Officer

WALTHAM, Mass. & VIENNA, Austria--(BUSINESS WIRE)--Arsanis, Inc., a clinical-stage biopharmaceutical company focused on monoclonal antibody approaches for the prevention and treatment of serious infectious diseases, today announced that Michael P. Gray has joined the company as chief financial officer and chief business officer.